Medicines Management for Nurses

at a Glance

Simon Young, Ben Pitcher

Multiple Choice: Chapter 49 Pharmacovigilance

Question 1. Nalmefene is a ‘black triangle’ drug. Why might this be the case?

A The drug is unlicensed
B The drug is being used off label
C The drug is undergoing additional monitoring (from a pharmacovigilance perspective)
D The drug has particularly toxic side effects